NovoRapid (NovoLog) FlexTouch Pens
Novolog Flexpens
Insulin Aspart
Select product strength & quantity:

Prescription Required.

Product of Canada.

Shipped from Canada.

Prescription Required.Product of Canada.Shipped from Canada.

Insulin is a hormone that is naturally produced by the pancreas, an organ in the body located behind the stomach.

For those with type 1 and type 2 diabetes, the body does not produce enough insulin or use it to properly to manage blood glucose levels. As a result glucose accumulates in the blood stream which can eventually lead to serious health complications or death.

Diabetics will typically require insulin to be injected under the skin (subcutaneously) which helps move glucose from the blood into other body tissues where it can be used as energy.

Modern insulin products such as NovoRapid (NovoLog) are improved versions of human insulin.

What is the NovoRapid FlexPen?

NovoRapid® (known as NovoLog in the US) FlexPen® 100 U/ml Solution was developed by the company Novo Nordisk.

It is an injectable pen that contains insulin aspart which is a rapid-acting insulin used to treat adults, adolescents and children with diabetes mellitus.

As advised by your doctor, your diabetes treatment should also include a healthy diet and regular exercise with your Novorapid Flexpen 100U/ml Injection 3ml.

Typically the FlexPen starts working 10-20 minutes after injection, a maximum effect occurs between 1 to 3 hours and lasts up to 3-5 hours. Due to it’s short onset of action, this insulin is usually combined with an intermediate-acting or long-acting insulin preparations.

Insulin should be taken at least 5-10 minutes prior to meals or within 20 minutes after starting your meal.

This fast-acting insulin ensures a rapid and consistent glucose management after meals. As a result, it stimulates the recovery of glucose in the muscle and fat cells and suppresses the production of glucose in the liver.

How to use NovoRapid FlexPen

Novorapid Flexpen 100U/ml Injection 3ml should be used 5-10 minutes prior to having a mean and injected in the upper thigh or abdomen (waist). Injecting in the abdomen provides faster absorption compared to other injection sites.

If you suddenly stop taking Novorapid Flexpen 100U/ml Injection you may experience withdrawal symptoms. Consult with you doctor before adjusting, rationing or stop taking your prescription insulin.

Always follow NovoRapid® FlexPen® instructions and dosage carefully and as advised by your doctor or